The Traderszone Network

Published in TZ Latest News 9 October, 2014 by The TZ Newswire Staff

Diplomat Pharmacy: Strong Industry Position Heading Into IPO

By Don Dion:

Diplomat Pharmacy (Pending:DPLO), the nation’s biggest independent specialty pharmacy that focuses on individuals with complex chronic diseases, plans to raise up to $245,333,328 in its upcoming IPO.

The Flint, Michigan based company will offer 13,333,333 shares at an expected price range of $14 to $16.

DPLO filed on July 3, 2014.

Lead Underwriters: Credit Suisse Securities, Morgan Stanley

read more